|
|
The Melanoma Care Coalition
Chair
John M. Kirkwood, MD
Professor and Vice Chairman for Clinical Research
Department of Medicine
University of Pittsburgh School of Medicine
Director, Melanoma Center
University of Pittsburgh Cancer Institute
Pittsburgh, PA
Consultant Attending Physician
VA Medical Center
Pittsburgh, PA
Grants/Research Support: Berlex Laboratories, Pfizer Inc, Schering Plough Corporation Promotional Speaker's Bureau: Schering-Plough Corporation
John M. Kirkwood, MD, is Director of the Melanoma and Skin Cancer Program at the University of Pittsburgh Cancer Institute and Professor and Vice Chairman for Clinical Research at the University of Pittsburgh School of Medicine. Dr Kirkwood has received international acclaim for his research in biologic agents, cancer vaccines, and molecular changes in melanoma.
The Melanoma Care Coalition
2012 Faculty Members
Denise Bachorski, RN, OCN
Collaborative Practice Nurse
University of Pittsburgh Cancer Institute
Hillman Cancer Center
Pittsburgh, PA
*Speaker's Bureau: Bristol-Myers Squibb
Keith T. Flaherty, MD
Director of Developmental Therapeutics
Dana Farber / Harvard Cancer Center
Massachusetts General Hospital Cancer Center
Boston, MA
*Consultant: GlaxoSmithKline and Roche/Genentech
Dave S. Hoon, MSc, PhD
Director, Molecular Oncology
Chief of Scientific Intelligence
John Wayne Cancer Institute
Santa Monica, CA
*Consultant: Nantworks, LLC/All About Advanced Health (AAAH and Advanced Diagnostics and Discovery)
Rene Gonzalez MD, FACP
Professor of Medicine
Director, Melanoma Research Clinics
University of Colorado Anschutz Medical Campus
Division of Medical Oncology
Aurora, CO
*Research Support: Bristol-Myers Squibb, Celgene, Roche/Genentech, Genta and GlaxoSmithKline
Antoni Ribas, MD, PhD
Professor of Medicine
Professor of Surgery
Professor of Molecular & Medical Pharmacology
University of California Los Angeles
Director, Tumor Immunology Program
Jonsson Comprehensive Cancer Center
Chair, Melanoma Committee at SWOG
Los Angeles, CA
*Consultant: Amgen, Celgene, Genentech, GlaxoSmithKline and Millennium
Ahmad A. Tarhini, MD, PhD
Assistant Professor of Medicine
Clinical and Translational Science Institute
University of Pittsburgh
Pittsburgh, PA
*Consultant: Genentech and Prometheus
Jedd D. Wolchok, MD, PhD
Director, Immunotherapy Clinical Trials, Department of Medicine
Associate Attending Physician, Melanoma-Sarcoma Service
Associate Director, Ludwig Center for Cancer Immunotherapy
Memorial Sloan-Kettering Cancer Center
New York, NY
*Consultant: Bristol-Myers Squibb
*Research Support: Bristol-Myers Squibb
The Melanoma Care Coalition
Past Faculty Members
Bruce J. Averbook, MD
Associate Professor of Surgery
Metro Health Medical Center
Case Western Reserve University
Cleveland, Ohio
*Speaker's Bureau: Schering Oncology Biotech
Matthew T. Ballo, MD
Associate Professor of Radiation Oncology
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*No financial relationships to disclose
Ernest C. Borden, MD
Director
Center for Cancer Drug Discovery & Development
Cleveland Clinic Cancer Center and Lerner Research Institute
The Cleveland Clinic Foundation
Cleveland, Ohio
*Consultant: Cleveland Biolabs; Speaker's Bureaus: Novartis Pharmaceuticals Corporation, Pfizer Inc
Tania Bridgeman, RN, PhD
Director of Clinical Path Development
University of California, Irvine Medical School
Orange, California
*No financial relationships to disclose
Clara Curiel-Lewandrowski, MD
Assistant Professor of Dermatology
University of Arizona
Tucson, Arizona
*No financial relationships to disclose
David E. Elder, MB, ChB, FRCPA
Professor of Pathology & Laboratory Medicine
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
*Grant Research Support: NIH/NCI, EU Framework
Marc S. Ernstoff, MD
Professor of Medicine
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
*Grants/Research Support: National Institutes of Health, Bristol-Myers Squibb, Berlex Laboratories, Chiron Inc, Schering-Plough Corporation, Pfizer Inc;
Consultant: Chiron Inc; Speaker's Bureaus: Berlex Laboratories, Chiron Inc, Schering-Plough Corporation, Pfizer Inc
Lawrence E. Flaherty, MD
Professor of Medicine and Oncology
Karmanos Cancer Institute
Wayne State University
Detroit, Michigan
*Grants/Research Support: Schering-Plough Corporation, Chiron Therapeutics, Celgene,Bayer; Consultant: Bayer; Speaker's Bureau: Schering-Plough Corporation, Glaxo Smith Kline
James S. Goydos, MD, FACS
Associate Professor of Surgical Oncology
Robert Wood Johnson Medical School
Cancer Institute of New Jersey
New Brunswick, New Jersey
*Speaker's Bureau: Schering-Plough Corporation
James M. Grichnik, MD, PhD
Associate Professor
Duke University Medical Center
Durham, North Carolina
*Founder and Major Shareholder: DigitalDerm, Inc; Consultant/Grants: Electro-Optical Systems Inc.
Caron M. Grin, MD
Clinical Professor of Dermatology
University of Connecticut Health Center
Farmington, Connecticut
*Speaker's Bureau: Schering-Plough Corporation
Rosemary Giuliano, ARNP, MSN
Surgical Hospitalist
Morton Plant North Bay Hospital
New Port Richey, Florida
*Consultant: Topo Target Speaker's Bureau: Schering-Plough Corporation, Topo Target, Genomic Health
James G. Jakowatz, MD
Director
Melanoma Center
Associate Professor of Surgery
University of California, Irvine Medical Center
Orange, California
*No financial relationships to disclose
Mohammed Kashani-Sabet, MD
Associate Professor of Dermatology
Director, Melanoma Center
UCSF Cancer Center
University of California San Francisco School of Medicine
San Francisco, California
*Consultant: Schering-Plough; Speaker's Bureau: Schering-Plough Corporation
Douglas Kondziolka, MD, MSc, FRCSC, FACS
Vice-Chairman of Neurological Surgery
Professor of Radiation Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania
*Consultant: Elekta Instruments
David H. Lawson, MD
Professor of Hematology/Oncology
Winship Cancer Institute
Atlanta, Georgia
*Grants/Research Support, Consultant, and Speaker's Bureaus: Chiron Therapeutics, Schering-Plough Corporation, Berlex Laboratories
Patricia K. Long, MSN, FNP
Physician Extender/Nurse Practitioner
University of North Carolina
Chapel Hill, North Carolina
*No financial relationships to disclose
Ashfaq A. Marghoob, MD, FAAD
Associate Clinical Member
Clinical Director, Skin Care Center
Memorial Sloan-Kettering Cancer Center
Hauppauge, New York
*No financial relationships to disclose
R. Dirk Noyes, MD, FACS
Co-Director
Surgical Oncology
Multidisciplinary Melanoma Clinic
University of Utah
Huntsman Cancer Institute
Salt Lake City, Utah
*Speaker's Bureau: Schering-Plough Corporation
Steven J. O'Day, MD
Director of Clinical Research
Director, Los Angeles Skin Cancer Institute
Beverly Hills Cancer Center
Los Angeles Skin Cancer Institute
Beverly Hills, CA
*Grants/Research Support: Berlex Laboratories, Chiron Therapeutics, Novartis, Schering-Plough Consultant: Synta Pharmaceuticals
Thomas E. Olencki, DO
Clinical Professor
Division of Hematology/Oncology
James Cancer Hospital and Solove Research Institute
Ohio State University
Columbus, Ohio
*Speaker's Bureaus: Schering-Plough Corporation
David W. Ollila, MD
Associate Professor of Surgery
Director, Multidisciplinary Melanoma Program
University of North Carolina School of Medicine
Chapel Hill, North Carolina
*No financial relationships to disclose
Victor G. Prieto, MD, PhD
Professor of Pathology
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*No financial relationships to disclose
Douglas S. Reintgen, MD
Director
Lakeland Regional Cancer Center
Lakeland, Florida
*Speaker's Bureau: Schering Oncology
Merrick I. Ross, MD, FACS
Professor of Surgical Oncology
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*Speaker's Bureaus: Schering-Plough Corporation, Genentech, Inc
Wolfram Samlowski, MD
Head, Section of Melanoma, Renal Cancer and Immunotherapy
Nevada Cancer Institute
Las Vegas, Nevada
*Grants/Research Support: Pfizer Inc; Speaker's Bureaus: Pfizer Inc, Bayer, AOI, Sci Med; Stockholder: Amgen, Pfizer, Chiron, Glaxo Smith Kline
Vernon K. Sondak, MD
Division Chief, Cutaneous Oncology
Director of Surgical Education
H. Lee Moffitt Cancer Center
Tampa, FL
*Speaker's Bureau: Schering-Plough Corporation, Pfizer, Inc
Kenneth K. Tanabe, MD
Chief
Division of Surgical Oncology
Massachusetts General Hospital
Associate Professor of Surgery
Harvard Medical School
Boston, Massachusetts
*Speaker's Bureau: Schering-Plough Corporation
Alan Valentine, MD
Associate Professor of Medicine
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*No financial relationships to disclose
Robert W. Weber, MD
Associate Director
Northern California Melanoma Center
St Francis Memorial Hospital
San Francisco, California
*No financial relationships to disclose
Richard L. White, Jr, MD, FACS
Clinical Associate Professor
Department of Surgery
Carolinas Medical Center
Blumenthal Cancer Center
Charlotte, North Carolina
*Speaker's Bureaus: Schering Oncology, Chiron Therapeutics
*Denotes financial disclosure information
|
